Series 4 episode 6: Hannah Robinson and Nick Thomas. Taking immunotherapy to delay adult-onset Type 1 diabetes

from One in Six Billion · host Andrew Hattersley and Maggie Shepherd

Hannah Robinson was the first adult in the UK to be given the new immunotherapy drug Teplizumab, which aims to slow down the development of type 1 diabetes. Hannah had multiple pancreatic autoantibodies and hence is on the path to developing Type 1 diabetes (Series 4 Episode 3). Her consultant, Nick Thomas, arranged 14 consecutive daily hospital visits for her to receive the drug through a drip. Send a text

Episode metadata supplied by the publisher feed · Published Sep 16, 2025

Embed this episode

Attribution link and audio player

NOW PLAYING

Series 4 episode 6: Hannah Robinson and Nick Thomas. Taking immunotherapy to delay adult-onset Type 1 diabetes

0:00 18:55

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of One in Six Billion?

This episode is 18 minutes long.

When was this One in Six Billion episode published?

This episode was published on September 16, 2025.

Can I download this One in Six Billion episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!